Naperol Investments Ltd
Incorporated in 1954, National Peroxide Ltd is engaged in Investment and Leasing business[1]
- Market Cap ₹ 661 Cr.
- Current Price ₹ 1,150
- High / Low ₹ 1,796 / 801
- Stock P/E
- Book Value ₹ 1,850
- Dividend Yield 0.09 %
- ROCE -0.08 %
- ROE -0.05 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.62 times its book value
- Market value of investments Rs.1,062 Cr. is more than the Market Cap Rs.661 Cr.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -65.6% over past five years.
- Company has a low return on equity of -0.04% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
212.24 | 234.22 | 196.29 | 233.22 | 232.97 | 305.55 | 401.50 | 207.91 | 226.29 | 232.17 | 1.89 | 1.92 | 1.92 | |
145.52 | 172.95 | 174.36 | 197.33 | 163.29 | 160.82 | 175.38 | 165.64 | 169.80 | 208.91 | 2.13 | 2.53 | 2.46 | |
Operating Profit | 66.72 | 61.27 | 21.93 | 35.89 | 69.68 | 144.73 | 226.12 | 42.27 | 56.49 | 23.26 | -0.24 | -0.61 | -0.54 |
OPM % | 31.44% | 26.16% | 11.17% | 15.39% | 29.91% | 47.37% | 56.32% | 20.33% | 24.96% | 10.02% | -12.70% | -31.77% | -28.12% |
5.07 | 7.06 | 6.37 | 7.16 | -1.50 | 11.20 | 19.11 | 0.69 | -14.53 | 10.45 | 376.33 | 0.00 | 0.00 | |
Interest | 0.35 | 0.22 | 4.68 | 5.39 | 2.21 | 0.51 | 0.73 | 2.74 | 12.66 | 8.83 | 0.00 | 0.00 | 0.00 |
Depreciation | 11.00 | 9.73 | 7.21 | 8.96 | 8.93 | 9.19 | 9.23 | 11.23 | 17.50 | 17.44 | 0.00 | 0.00 | 0.00 |
Profit before tax | 60.44 | 58.38 | 16.41 | 28.70 | 57.04 | 146.23 | 235.27 | 28.99 | 11.80 | 7.44 | 376.09 | -0.61 | -0.54 |
Tax % | 34.13% | 33.85% | 61.97% | 37.39% | 33.59% | 34.95% | 34.96% | 40.12% | -76.44% | 31.72% | 0.22% | -40.98% | |
39.81 | 38.62 | 6.23 | 17.97 | 37.88 | 95.12 | 153.03 | 17.37 | 20.81 | 5.09 | 375.25 | -0.37 | -0.37 | |
EPS in Rs | 69.84 | 67.75 | 10.93 | 31.53 | 66.46 | 166.88 | 268.47 | 30.47 | 36.51 | 8.93 | 658.33 | -0.65 | -0.65 |
Dividend Payout % | 21.67% | 22.33% | 46.15% | 32.00% | 51.61% | 39.29% | 24.42% | 41.38% | 34.54% | 56.48% | 0.15% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -38% |
5 Years: | -66% |
3 Years: | -80% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 34% |
Stock Price CAGR | |
---|---|
10 Years: | 10% |
5 Years: | 1% |
3 Years: | -11% |
1 Year: | 7% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 2% |
3 Years: | 0% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 |
Reserves | 172.30 | 200.84 | 203.20 | 214.25 | 368.46 | 503.10 | 609.34 | 480.71 | 582.67 | 531.50 | 551.58 | 1,049.01 |
1.03 | 4.04 | 72.99 | 30.33 | 11.04 | 0.00 | 79.69 | 161.38 | 124.69 | 94.07 | 0.00 | 0.00 | |
57.23 | 58.92 | 62.17 | 59.96 | 54.62 | 75.69 | 88.10 | 94.41 | 71.43 | 62.94 | 1.47 | 23.22 | |
Total Liabilities | 236.31 | 269.55 | 344.11 | 310.29 | 439.87 | 584.54 | 782.88 | 742.25 | 784.54 | 694.26 | 558.80 | 1,077.98 |
110.42 | 116.63 | 187.37 | 179.67 | 178.48 | 169.65 | 165.75 | 372.39 | 342.13 | 337.66 | 0.06 | 0.06 | |
CWIP | 3.15 | 40.92 | 3.98 | 3.09 | 1.68 | 5.64 | 75.40 | 0.00 | 2.53 | 3.99 | 0.00 | 0.00 |
Investments | 58.61 | 10.29 | 9.59 | 7.06 | 170.19 | 253.43 | 191.59 | 176.56 | 267.74 | 281.73 | 546.81 | 1,064.72 |
64.13 | 101.71 | 143.17 | 120.47 | 89.52 | 155.82 | 350.14 | 193.30 | 172.14 | 70.88 | 11.93 | 13.20 | |
Total Assets | 236.31 | 269.55 | 344.11 | 310.29 | 439.87 | 584.54 | 782.88 | 742.25 | 784.54 | 694.26 | 558.80 | 1,077.98 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
41.27 | 27.75 | 21.07 | 21.83 | 59.29 | 94.22 | 147.54 | 15.58 | 60.74 | 9.17 | 1.45 | 1.09 | |
-28.76 | -20.51 | -74.98 | 29.50 | -31.34 | -55.87 | -174.61 | -38.28 | -7.08 | 34.27 | 0.95 | 0.45 | |
-12.50 | -7.24 | 54.26 | -51.38 | -28.24 | -35.21 | 34.66 | 14.13 | -49.18 | -49.08 | -2.88 | -0.62 | |
Net Cash Flow | 0.01 | 0.00 | 0.35 | -0.05 | -0.29 | 3.13 | 7.59 | -8.58 | 4.47 | -5.64 | -0.49 | 0.92 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 54.46 | 50.66 | 69.10 | 51.11 | 51.97 | 63.61 | 27.81 | 56.62 | 38.45 | 29.68 | 193.12 | 0.00 |
Inventory Days | 56.17 | 134.14 | 75.95 | 64.53 | 66.26 | 65.32 | 133.93 | 98.14 | 86.78 | 86.85 | ||
Days Payable | 174.75 | 125.97 | 119.58 | 82.59 | 114.69 | 89.84 | 100.97 | 75.09 | 102.50 | 41.02 | ||
Cash Conversion Cycle | -64.12 | 58.83 | 25.47 | 33.05 | 3.54 | 39.09 | 60.78 | 79.66 | 22.74 | 75.51 | 193.12 | 0.00 |
Working Capital Days | 25.66 | 71.90 | 149.89 | 101.52 | 64.05 | 114.93 | 237.71 | 229.82 | 196.80 | 42.20 | -84.97 | -302.27 |
ROCE % | 36.55% | 29.59% | 8.56% | 13.15% | 21.05% | 32.59% | 39.21% | 4.73% | 5.87% | 1.29% | -0.04% | -0.08% |
Documents
Announcements
-
Summary Of Proceedings Of The Annual General Meeting
24h - Summary of Proceedings of the Annual General Meeting - Disclosure under Regulation 30, Part A of Schedule III of SEBI (LODR) Regulations, 2015.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 1d
- Shareholder Meeting / Postal Ballot-Outcome of AGM 1d
-
Announcement under Regulation 30 (LODR)-Change in Directorate
10 Aug - Mr. Rajesh Kumar Batra, Independent Director of the Company has completed his second term of 5 years and consequently ceased to be an Independent Director …
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 Aug - Submission of newspaper advertisement of Notice of 70th Annual General Meeting, Voting information and Book Closure
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
a) Manufacturing, distribution and dealing
of peroxygen chemicals
b) Making long term investments and corporate lending directly and/or through its wholly owned subsidiary viz., the Transferor Company.